IntelliPharmaCeutics International Inc (IPCIF)
0.10
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
IntelliPharmaCeutics International Market Cap: 3.309M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 10, 2024 | 3.309M |
| May 09, 2024 | 3.309M |
| May 08, 2024 | 3.309M |
| May 07, 2024 | 1.986M |
| May 06, 2024 | 1.986M |
| May 03, 2024 | 1.986M |
| May 02, 2024 | 1.986M |
| May 01, 2024 | 1.986M |
| April 30, 2024 | 1.986M |
| April 29, 2024 | 1.986M |
| April 26, 2024 | 1.986M |
| April 25, 2024 | 1.986M |
| April 24, 2024 | 1.986M |
| April 23, 2024 | 1.986M |
| April 22, 2024 | 3.971M |
| April 19, 2024 | 1.986M |
| April 18, 2024 | 2.316M |
| April 17, 2024 | 4.468M |
| April 16, 2024 | 4.468M |
| April 15, 2024 | 1.986M |
| April 12, 2024 | 1.986M |
| April 11, 2024 | 2.333M |
| April 10, 2024 | 2.333M |
| April 09, 2024 | 2.333M |
| April 08, 2024 | 2.396M |
| Date | Value |
|---|---|
| April 05, 2024 | 2.340M |
| April 04, 2024 | 2.340M |
| April 03, 2024 | 2.340M |
| April 02, 2024 | 2.519M |
| April 01, 2024 | 2.806M |
| March 28, 2024 | 2.355M |
| March 27, 2024 | 1.986M |
| March 26, 2024 | 2.647M |
| March 25, 2024 | 1.655M |
| March 22, 2024 | 2.694M |
| March 21, 2024 | 2.694M |
| March 20, 2024 | 1.344M |
| March 19, 2024 | 0.9266M |
| March 18, 2024 | 2.479M |
| March 15, 2024 | 2.479M |
| March 14, 2024 | 0.8439M |
| March 13, 2024 | 0.8439M |
| March 12, 2024 | 0.8439M |
| March 11, 2024 | 0.9928M |
| March 08, 2024 | 1.555M |
| March 07, 2024 | 1.555M |
| March 06, 2024 | 1.555M |
| March 05, 2024 | 1.555M |
| March 04, 2024 | 1.555M |
| March 01, 2024 | 1.539M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
0.0397M
Minimum
May 09 2023
20.32M
Maximum
Jan 03 2020
3.704M
Average
3.339M
Median
Jun 03 2020
Market Cap Benchmarks
| Acasti Pharma Inc | 25.94M |
| Aurinia Pharmaceuticals Inc | 717.96M |
| Edesa Biotech Inc | 14.62M |
| Lexaria Bioscience Corp | 45.74M |
| Xenon Pharmaceuticals Inc | 3.059B |
Market Cap Related Metrics
| PS Ratio | 4.061 |
| Price to Free Cash Flow | 30.51 |
| Price | 0.10 |
| Earnings Yield | -92.00% |